Influence of KDR Genetic Variation on the Efficacy and Safety of Patients with Chemotherapy Refractory Metastatic CRC Who Received Apatinib Treatment
Ming Bai,1,* Zhi-Guo Li,2,* Yi Ba1 1Department of Gastrointestinal Oncology, Affiliated Tumor Hospital of Tianjin Medical University, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key L...
Main Authors: | Bai M, Li ZG, Ba Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-03-01
|
Series: | International Journal of General Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/influence-of-kdr-genetic-variation-on-the-efficacy-and-safety-of-patie-peer-reviewed-article-IJGM |
Similar Items
-
Clinical Outcomes and Safety of Apatinib Mesylate in the Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Patients Who Progressed After Standard Therapy and Analysis of the KDR Gene Polymorphism
by: Song ZZ, et al.
Published: (2020-01-01) -
Low-Dose Apatinib Combined With S-1 in Refractory Metastatic Colorectal Cancer: A Phase 2, Multicenter, Single-Arm, Prospective Study
by: Ning Li, et al.
Published: (2021-09-01) -
Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report
by: Lishu Yang, et al.
Published: (2018-05-01) -
Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review
by: Bi MH, et al.
Published: (2018-02-01) -
Safety and efficacy of combination therapy with apatinib and doxorubicin in metastatic soft tissue sarcomas: an observational study from multiple institutions
by: Tian Z, et al.
Published: (2019-06-01)